HE4, encoded by the WFDC2 gene, is a well-established biomarker for ovarian cancer diagnosis and monitoring, with elevated serum levels strongly correlating with poor clinical outcomes [13,14]. Here, WFDC2 is linked to ovarian carcinoma.